Metraipolis › archive › dc_27c1bb765a0e

5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity — Europe PMC PMID:42123875

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123875
DOI
10.3390/molecules31091511
License (as archived)
solo-consultazione
Archived
2026-11-02T19:55:15.979Z
SHA-256 of the archived text
129721f57fc09487debef550fbdae3e9743b5a92e13c862ed977ad9d7032ec81
Stable URL of this page
https://metraipolis.com/documento/dc_27c1bb765a0e

How to cite

5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity — Europe PMC PMID:42123875 — Europe PMC (en), https://europepmc.org/article/MED/42123875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27c1bb765a0e (Metraipolis archive dc_27c1bb765a0e, sha256 129721f57fc09487debef550fbdae3e9743b5a92e13c862ed977ad9d7032ec81)
BibTeX
@misc{dc27c1bb765a0e,
  title = {5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity — Europe PMC PMID:42123875},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123875},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27c1bb765a0e; sha256 129721f57fc09487debef550fbdae3e9743b5a92e13c862ed977ad9d7032ec81},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123875. Agents can read the archived copy with the MCP tool read_document.